Antitumor activity of new chemical agents in mammary adenocarcinoma models
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-A-012-Monday
- By: GIOLITO, María Virginia (Instituto de Genetica Experimental, Oncology, Rosario, Argentina)
- Co-author(s): María Virginia Giolito: Oncology, Instituto de Genetica Experimental, Rosario, Argentina
Patricia Cornier: Medicinal Chemistry, IQUIR - CONICET, Rosario, Argentina
Carina Delpiccolo: Medicinal Chemistry, IQUIR - CONICET, Rosario, Argentina
Antonela Del Giúdice : Oncology, Instituto de Genetica Experimental, Rosario, Argentina
Dora B. Boggian: Medicinal Chemistry, IQUIR - CONICET, Rosario, Argentina
Mauricio Menacho Marquez: Oncology, Instituto de Genetica Experimental, Rosario, Argentina;, conicet, Rosario, Argentina
Leandro Mainetti: Oncology, Instituto de Genetica Experimental, Rosario, Argentina;, conicet, Rosario, Argentina
O. Graciela Scharovsky: Oncology, Instituto de Genetica Experimental, Rosario, Argentina;, conicet, Rosario, Argentina;, cic-unr, Rosario, Argentina
Ernesto Mata: Medicinal Chemistry, IQUIR - CONICET, Rosario, Argentina
Viviana Rozados: Oncology, Instituto de Genetica Experimental, Rosario, Argentina
María José Rico: Oncology, Instituto de Genetica Experimental, Rosario, Argentina;, conicet, Rosario, Argentina - Abstract:
Backgrounds
New antitumor agents are needed due to the toxicity of the antitumor drugs, the development of resistance and the scarcity of effective therapies.
Aims
To evaluate antitumor activity of novel compounds and their mechanisms of action.Methods
In vitro a)We tested the antitumor activity (WST1) of 44 novel compounds: aminoacyl/peptidyl.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023